ACCP Annual Meeting Invited Keynote

Bruce C. Carleton, PharmD
Professor of Pediatrics & Chair, Div of Translational Therapeutics, Faculty of Medicine, Univ of British Columbia; Director, Pharmaceutical Outcomes Program, BC Children’s Hosp; Senior Clinician Scientist, BC Children’s Hosp Research Inst

Pharmacogenomics & Risk Decision Making: Putting Patients First

Dr. Carleton’s lifelong goal is to make medication use more effective and safer for all patients, particularly children. His research focus is on the impact of drug therapy on human health and quality of life. He is particularly interested in developing better ways to evaluate the effectiveness of drugs and medication-use models designed to improve patient health, as well as practical surveillance systems to improve the safe use of medication.

A key element of Dr. Carleton's research is the communication of results to clinicians, patients, healthcare administrators and government officials who hold the responsibility of improving patient care and systems of healthcare delivery.

In addition to his appointment as Professor of Pediatrics and Chair of the Div of Translational Therapeutics, Dept of Pediatric Medicine at the Univ of British Columbia (UBC), Dr. Carleton is a Senior Clinician Scientist at BC Children’s Hosp Research Inst.  He directs the Pharmaceutical Outcomes Program at BC Children’s Hosp and has served in that capacity since 1994.  He holds appointments at UBC in the Ctr for Health Services & Policy Research, the School of Population & Public Health and the Faculty of Pharmaceutical Sciences and the School of Health Information Science, Univ of Victoria.  Dr. Carleton’s public service is expansive and includes serving as a charter member on the national Canadian Expert Drug Advisory Committee.  Dr. Carleton was recently asked to serve the US Government as a Special Government Employee to advise the Advisory Committee for Pharmaceuticals & Clinical Pharmacology of the US Food & Drug Administration.